Abstract
Between February and November 1983, 108 recipients of cadaveric renal transplants entered a randomized multicenter trial and were treated either with cyclosporine (CsA) and prednisone (n=55) or with conventional treatment based on azathioprine (Aza) and glucocorticoids (n=53). The graft survival probability at 3 years was 76% for CsA patients and 48% for Aza patients (P
Original language | English |
---|---|
Pages (from-to) | 908-913 |
Number of pages | 6 |
Journal | Transplantation |
Volume | 45 |
Issue number | 5 |
Publication status | Published - 1988 |
ASJC Scopus subject areas
- Transplantation
- Immunology